Santo Domingo, DR—The Ministry of Public Health reported in its epidemiological bulletin for week 31 that the Doctor Defilló National Reference Laboratory processed 36 respiratory samples.
It also highlights that multiple respiratory viruses, such as Covid-19 ( SARS-CoV-2 ) and metapneumovirus, are currently actively circulating.
The Ministry of Public Health urges the population to get vaccinated and follow key community measures such as handwashing, mask use for symptomatic individuals, adequate ventilation, and avoiding self-medication.
Additionally, seek medical attention if you experience respiratory symptoms to help contain transmission and protect the most vulnerable populations.
It indicates that if the patient has a persistent fever or difficulty breathing, they should go to a health center immediately.
It also suggests seeking guidance only from official sources and avoiding disseminating unverified information.
Against hepatitis
In another order, the epidemiological bulletin also highlights the warning made by the World Health Organization (WHO) in commemoration of World Hepatitis Day, that type D of this disease is carcinogenic.
“Every 30 seconds, someone dies from a serious liver disease or liver cancer linked to hepatitis, even though we have the means to stop the disease,” said WHO Director-General Dr. Tedros Adhanom Ghebreyesus.
He indicated that viral hepatitis, types A, B, C, D, and E, are important causes of acute liver infection.
He stated that of these hepatitis types, only types B, C, and D can cause chronic infections that significantly increase the risk of cirrhosis, liver failure, or liver cancer. Still, most people with this disease don’t know they’re infected.
He also noted that these three types affect more than 300 million people worldwide and cause more than 1.3 million deaths each year, primarily from liver cirrhosis and cancer.
The International Agency for Research on Cancer (IARC) recently classified hepatitis D as carcinogenic to humans, along with hepatitis B and C.
He indicated that this type of hepatitis, which only affects people with hepatitis B, is associated with a risk of liver cancer two to six times greater than if the person has hepatitis B alone.
“In 2024, WHO published guidelines on testing and diagnosis for hepatitis B and D and is actively monitoring clinical endpoints for innovative hepatitis D treatments,” said Dr. Meg Doherty, the new director of the Department of Science for Health at WHO.
Last July, the Ministry of Public Health (MSP) reported that the National Epidemiological Surveillance System (Sinave) had recorded 910 cases of hepatitis B nationwide so far this year. The highest incidence of cases was reported in men.
Regarding hepatitis C, 541 cases were reported, with women being the most affected.
The disease
Hepatitis is defined as the inflammation of the liver, caused by one of the many viruses that exist, whether A, B, C, D, or E.
According to specialists, these types of viruses are transmitted through unprotected sex, contact with contaminated food and drinks, and contact with bodily fluids from infected people.
Symptoms
Symptoms of hepatitis include extreme fatigue, nausea and vomiting, diarrhea, low-grade fever, dark urine, pale stools, abdominal pain, loss of appetite, and yellowing of the skin and eyes.
Treatment
The WHO reported that oral medication can cure hepatitis C within two to three months, and can also control the virus with lifelong treatment.
He highlighted that testing and treatment coverage are low, noting that 13% of people with hepatitis B and 36% of those already living with the disease were diagnosed in 2022, making expanding coverage for prevention, testing, and treatment of this disease a challenge.